Matthew V. Beck

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

Eric Vallabh Minikel, Hien Zhao, Jason Le et al. · Nucleic Acids Research · 2020 · 130 citations · Full text

Creutzfeldt-jakob Disease, Pathology, Neurochemical Biomarkers +20

Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis

Cheng Zhu, Matthew V. Beck, Jack D. Griffith et al. · Proceedings of the National Academy of Sciences · 2018 · 92 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Medicine +14

MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation

Vijay Swahari, Ayumi Nakamura, Émilie Hollville et al. · Cell Reports · 2021 · 71 citations · Full text

Telomerase inhibition is an effective therapeutic strategy in<i>TERT</i>promoter-mutant glioblastoma models with low tumor volume

Elisa Aquilanti, Lauren Kageler, Jacqueline Watson et al. · Neuro-Oncology · 2023 · 27 citations · Full text

Loss of ATM positively regulates Rac1 activity and cellular migration through oxidative stress

Caitlin E. Tolbert, Matthew V. Beck, Claire E. Kilmer et al. · Biochemical and Biophysical Research Communications · 2018 · 10 citations